胎盤幹細胞を使用する腫瘍抑制 - Antofrogenesis Corporation

Title:

胎盤幹細胞を使用する腫瘍抑制

Document Type and Number:

Japanese Patent JP2010501159

Kind Code:

A

Abstract:

The invention provides isolated cell populations comprising placental stem cells, wherein said placental stem cells (a) adhere to a substrate, (b) express specific cells markers, and (c) detectably suppress proliferation of a plurality of tumor cells, as compared to a plurality of tumor cells not contacted with placental stem cells. Methods of producing a cell population comprising placental stem cells, compositions comprising the isolated placental stem cell population, and the isolated placental stem cell population for use in a method for treatment of an individual having tumor are also provided.

More Like This:

JP5431786	Systems and methods for isolating, ex vivo proliferation and recovery of hematopoietic stem cells
JP2003000242	CYTOTOXIC T LYMPHOCYTE
JP4516916	HLA-A24 binding cancer antigen peptide derived from Ribin

Inventors:

Kasper Pardin
James edingel
Ruihol Harbak Keuski
Roseanne Murray
Roberto Jay Hariri

Application Number:

JP2009522903A

Publication Date:

January 21, 2010

Filing Date:

August 06, 2007

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Antofrogenesis Corporation

International Classes:

C12N5/07; A61K35/50; A61P35/00; A61P35/02; C12N5/073; C12N5/0775; C12N5/09

Domestic Patent References:

JP2004057198A

2004-02-26

Other References:

JPN6012040135; Ｅｘｐ．Ｍｏｌ．Ｐａｔｈｏｌ．Ｖｏｌ．７５, 2003, ｐ．２４８-２５５
JPN6012040137; ＨａｅｍａｔｏｌｏｇｉａＶｏｌ．９１, 20060201, ｐ．１９２-１９９
JPN6012040138; Ａｍ．Ｊ．Ｏｂｓｔｅｔｒｉｃｓ　Ｇｙｎｅｃｏｌ．Ｖｏｌ．１９４, 200603, ｐ．６６４-６７３
JPN6012040140; Ｃａｎｃｅｒ　Ｒｅｓ．Ｖｏｌ．６２, 2002, ｐ．３６０３-３６０８
JPN6012040142; Ａｍ．Ｊ．Ｒｅｐｒｏｄ．Ｉｍｍｕｎｏｌ．Ｖｏｌ．５０, 2003, ｐ．１８７-１９５

Attorney, Agent or Firm:

Toru Ishikawa

Previous Patent: JP2010501158

Next Patent: 無差別ＨＥＲ−２／ＮｅｕＣＤ４Ｔ細胞エピトープ